Pitt Street Research | Stock research
Curvebeam AI.png

Curvebeam AI

CurveBeam AI (ASX:CVB) is a medical technology company that is developing and commercialising medical CT scanners. The company’s current flagship product, is HiRise which has been FDA cleared since 2020 and is a 3rd generation product. CVB also has AI algorithms underpinning its scanners and are eventually intended to be commercialised as stand-alone products.

CurveBeam AI (ASX:CVB)

 

CurveBeam AI (ASX:CVB) is a medical technology company that is developing and commercialising medical CT scanners. The company’s current flagship product, is HiRise which has been FDA cleared since 2020 and is a 3rd generation product. CVB also has AI algorithms underpinning its scanners and are eventually intended to be commercialised as stand-alone products.